Free access supported by contributions and sponsoring — share your knowledge or support us financially
Search / Compare / Validate Lab equipment & Methods

Oil red o

Manufactured by Merck Group
Sourced in United States, Germany, China, Sao Tome and Principe, Japan, United Kingdom, Italy, France, Macao, Switzerland, Australia, Canada, Spain, Denmark, Sweden, India, Belgium, Singapore, Poland
About the product

Oil Red O is a fat-soluble dye used in histology and cell biology for the staining of neutral lipids, such as triglycerides and cholesterol esters. It is a useful tool for the identification and visualization of lipid-rich structures in cells and tissues.

Automatically generated - may contain errors

4 378 protocols using oil red o

1

Histological Analysis of Muscle Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
For histological analysis, the excised muscle tissues were fixed in 10% neutral-buffered formalin prior to being embedded in paraffin or OCT compounds. For hematoxylin and eosin (H&E) staining, 5 µm sections of paraffin-embedded muscle were utilized. Frozen liver, Quadriceps muscle (Qua. muscle), and tibialis anterior (TA) muscle sections were stained with oil-red O (Sigma-Aldrich) in 60 % isopropanol. Staining intensity was quantified using Image-Pro Plus software.
+ Open protocol
+ Expand
2

Adipogenic Differentiation and Oil Red O Staining

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were plated in a 6-well plate and allowed to reach confluence. To induce adipogenic differentiation, biotin (33 µM), pantothenic acid (17 µM), rosiglitazone (10 µM), insulin (1 µM), transferrin (10 µg/mL), dexamethasone (1 µM), triiodothyronine (0.2 µM), and 3-isobutyl-1-methylxanthine (IBMX; 0.1 mM) were added. Differentiation was continued for 14 days, with the culture medium replaced every 2 to 3 days. Dexamethasone and IBMX were removed from the medium from day 4 onward. To evaluate the effect of silencing SerpinA3 on adipogenic differentiation, the cells were transfected with si-SerpinA3 during differentiation, according to the manufacturer's instructions.
For Oil Red O staining, a working solution was prepared by diluting a stock solution of Oil Red O (Sigma-Aldrich, Burlington, MA, USA) with distilled water (6:4). Subsequently, the solution was filtered through a 0.2-µm filter. After the induction of differentiation, the cells were washed with warm PBS and fixed with 10% formalin at 4°C for 1 hour. The cells were washed with PBS and dried with 60% isopropanol for 5 minutes. Isopropanol was removed and the cells were stained with Oil Red O solution for 1 to 2 hours at room temperature and washed again with distilled water. The stained cells were examined and visualized under a microscope. Once the cells had completely dried, isopropanol was added to solubilize the cell-bound Oil Red O for quantification. Absorbance was measured at 490 nm using a spectrophotometer.
+ Open protocol
+ Expand
3

Multilineage Differentiation of hUCB-MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
A multilineage differentiation assay was performed to assess the capacity of hUCB-MSC to differentiate into osteoblasts, chondroblasts,
and adipocytes in vitro. Passage 5 hUCB-MSCs were differentiated into osteoblasts, chondroblasts, and adipocytes using the MesenCult Osteogenic Differentiation Kit (Human) (StemCell Technologies, Canada), MesenCult-ACF Chondrogenic Differentiation Kit (StemCell Technologies, Canada), and MesenCult Adipogenic Differentiation Kit (Human) (StemCell Technologies, Canada), following the manufacturer’s protocols. After culture in the differentiation media for 14 days, hUCB-MSCs were fixed with 4% paraformaldehyde (Wako, Japan), and stained with alizarin red (Sigma-Aldrich, USA), alcian blue (Sigma-Aldrich, USA), and oil red O (Sigma-Aldrich, USA) stains to assess osteogenic, chondrogenic, and adipogenic differentiation, respectively. Differentiated hUCB-MSCs were then observed and documented under an Axiovert inverted light microscope (Zeiss, Germany).
+ Open protocol
+ Expand
4

Chondrocyte Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Ascorbate 2-phosphate, β-glycerophosphate, paraformaldehyde (PFA), trypsin–EDTA, 2-amino-2-methyl-1-propanol (AMP), o-cresolphthalein complexon, 8-Hydroxyquinoline, Bovine serum albumin (BSA), Safranin O, Tween20, Kolliphor®P188 were obtained from Sigma (Taufkirchen, BY, Germany). L-Prolin, sodium-pyruvate, acetic acid, hydrochloric acid (HCl) and crystal violet were received from Roth (Karlsruhe, BW, Germany). Protease inhibitor cocktail, DAPI and insulin were bought from Roche (Mannheim, BW, Germany). Resazurin was purchased from Santa Cruz Biotechnology (Heidelberg, BW, Germany). Fetal bovine serum (FBS) was from Capricorn Scientific (Ebsdorfergrund, HE, Germany). ITS-G premix, high / low glucose medium (4.5 g/L) and Dulbecco’s Modified Eagle’s medium (DMEM/F-12) were obtained from Life Technologies (Darmstadt, HE, Germany). ∆9-tetrahydrocannabinol (Dronabinol) was bought from LGC (Wesel, NW, Germany). Collagenase (type I) was purchased from Worthington Biochemical Corp. (Lakewood, NJ, USA). Transforming growth factor-β3 (TGF-β3) was obtained from PeproTech (Hamburg, HH, Germany). 2-propanol and Oil Red O was bought from Merck (Darmstadt, HE, Germany).
+ Open protocol
+ Expand
5

Oil Red O Lipid Staining Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Samples were stained with Oil Red O (ORO) (Sigma-Aldrich, Germany) according to themanufacturer’s protocol [37 (link)]. Sections of 10 µm thick were obtained on a Microm HM-525 cryostat (Thermo Scientific, USA) and mounted on Menzel-Glaser glasses (Thermo Scientific), washed with 60% isopropanol, incubated in 0.5% ORO solution (Sigma-Aldrich) for 10 min, and washed them again with 60% isopropanol and distilled water. The histological preparations and photographs were studied on an AxioImaiger A1 light microscope (Carl Zeiss, Germany) using the AxioVision 4.7.1.0 image analysis program (Carl Zeiss). ORO staining density was determined using ImageJ software (USA).
+ Open protocol
+ Expand
6

Molecular Mechanisms of Endothelial-Mesenchymal Transition

Check if the same lab product or an alternative is used in the 5 most similar protocols
FSH (no. F4021), Oil Red O (ORO) (no. O0625), phenylmethanesulfonyl fluoride (PMSF) (no. 78830), protease inhibitor cocktail (PIC) (no. P8340), phosphatase inhibitor cocktail (PHIC) (no. P0044), NaF (no. S6776), and penicillin–streptomycin solution (no. V900929) were acquired from Sigma-Aldrich (St. Louis, MO, USA). Cluster of differentiation (CD)31 (no. 2528S), von Willebrand factor (vWF) (no. 65707S), vascular endothelial (VE)-cadherin (no. 2500S), alpha smooth muscle actin (α-SMA) (no. 19245S), fibroblast activation protein (FAP) (no. 66562S), FOXM1 (no. 20459S), SNAIL (no. 3879S), SLUG (no. 9585S), and Twist1 (no. 90445S), total-CREB (no. 9104S), and phospho-CREB (Ser133) (no. 9198S) antibodies were obtained from Cell Signaling Technology (Danvers, MA, USA). SM22α (no. ab14106) and ALKBH5 (no. ab195377) were purchased from Abcam (Boston, MA, USA); GAPDH (no. SC-47724) was acquired from Santa Cruz Biotechnology (Dallas, TX, USA). Phospho-CREB (Ser129, Ser133) (no. 44297G) antibody was procured from Thermo Fisher Scientific (Rockford, IL, USA). Actinomycin D (no. HY-17559) was sourced from MedChemExpress (NJ, USA). The Magna MeRIP™ m6A Kit (no. 17-371) and RNA immunoprecipitation (RIP) Kit (no. 17-700) were purchased from Millipore (MA, USA). Luciferase reporter gene test kit (no. E1910) was obtained from Promega (Beijing, China).
+ Open protocol
+ Expand
7

Histological Assessment of Liver Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fixed liver tissue samples were embedded in paraffin blocks and sectioned into 4 µm thick serial slices. The tissue sections were subsequently stained with hematoxylin and eosin (H&E) (Yeasen Biotechnology Co., Ltd., Shanghai, China) to evaluate liver tissue morphology, with Oil Red O (Sigma-Aldrich Co., St. Louis, MO, USA) to visualize lipid droplet accumulation, and with Masson’s trichrome stain (G-Biosciences, St. Louis, MO, USA) to assess the extent of fibrotic changes.
+ Open protocol
+ Expand
8

Measuring LDL Uptake in Huh-7 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Huh-7 cells (~0.5 × 106 cells) were seeded in 24-well plates and maintained overnight in DMEM growth medium supplemented with 2% FCS and 1% P/S. Cells were first incubated with AMD3100 (10 μg/mL), anti-human CD74 (LN2) (10 μg/mL), or IgG control for 1 h at 37 °C and then stimulated with 8 nM MIF-2 (100 ng/mL) for 24 h. Cells were treated with serum-free medium containing 25 μg/mL native LDL for 4 h. Excess LDL was removed by washing the cells thoroughly with PBS followed by fixation with 4% PFA for 20 min at RT with gentle shaking. Cells were washed extensively and stained with Oil-Red-O (ORO, Sigma-Aldrich) for 10 min. Cell nuclei were counterstained with DAPI for 5 min at RT in the dark, and LDL uptake was analyzed and visualized using a Leica DMi8 microscope.
+ Open protocol
+ Expand
9

Murine and Human Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
The murine mesenchymal stem cell line, C3H10T1/2, was kindly donated by Prof. Eduardo Domínguez Medina (University of Santiago de Compostela, Spain) and cultured at 37 °C under 5% CO2 in DMEM (4.5 g/L glucose, Corning, USA) containing 10% fetal bovine serum (FBS; Sigma-Aldrich, MO, USA) and 1% penicillin and streptomycin (P/S, Biowest) until differentiation into adipocytes, as previously described [19 (link)]. In brief, differentiation was performed after cell confluence with induction medium [maintenance medium supplemented with 1 µM dexamethasone, 0.5 mM isobutylmethylxanthine, 1 µM rosiglitazone (Sigma-Aldrich, MO, USA), and 5 µg/mL insulin (Actrapid, NovoNordisk)]. Two, four, and 6 days after induction, the medium was replaced with maintenance medium containing 5 µg/mL insulin (Actrapid, NovoNordisk). The accumulation of cytoplasmic triglycerides in these cells was detected by staining with Oil Red O (Sigma-Aldrich, MO, USA).
A high-glucose and high-insulin (HG/HI) insulin resistance, and lipid hypertrophy/insulin resistance cell models were established as described previously [11 (link), 20 (link)]. Briefly, cells were differentiated until day 6, washed three times with PBS, and incubated for 2 h in low-glucose (1 g/L) and serum-free cell culture medium. Cells were then cultured in high glucose (4.5 g/L) and high insulin (100 nM), or with palmitate (500 µM in 2% fatty acid-free BSA [Capricorn Scientific, USA]) or oleic acid [1 mM, conjugated in 0.5 mM fatty acid-free BSA [Capricorn Scientific, USA]) in serum-free medium for 24 h in oleic and HG/HI, and 18 h in palmitate. For vesicle isolation, the treatment was prolonged to 48 h. For pAkt/Akt pathway analysis, cells were washed three times in PBS and stimulated with insulin (100 nM) for 10 min.
The murine macrophages Raw 264.7 cells were cultured in DMEM (4.5 g/L glucose, Lonza) containing 10% fetal bovine serum (Sigma-Aldrich, MO, USA) and 1% P/S (Biowest) at 37 °C under 5% CO2.
Human macrophage THP-1 cells were cultured in RPMI (without L-Glutamine, Lonza) containing 10% FBS (Sigma-Aldrich, MO, USA), 1% P/S (Biowest) and 0.05 mM β-mercaptoethanol at 37 °C under 5% CO2. THP-1 monocytes were differentiated into macrophages by adding 5 µg/mL Phorbol Myristate Acetate (PMA) for 24 h. For RNA extraction, the treatment was performed for 24 h, whereas for the isolation of vesicles in the cell secretome, the treatment was prolonged to 48 h.
The human hepatocytes HepaRG cells were cultured in William’s E medium supplemented with GlutaMAX (Gibco) containing 10% fetal bovine serum (FBS; Sigma-Aldrich, MO, USA) and 1% P/S (Biowest) at 37 °C under 5% CO2. However, before differentiation, HepaRG cells were cultured in proliferation medium [maintenance medium with 5 µg/mL insulin (Actrapid, NovoNordisk) and 0.5 µM hydrocortisone hemisuccinate sodium salt (Sigma-Aldrich, MO, USA) for 6 days, renewing the medium every two days. HepaRG cells were differentiated using differentiation medium [maintenance medium with 5 µg/mL insulin (Actrapid, NovoNordisk), 50 µM hydrocortisone hemisuccinate sodium salt, and 2% dimethyl sulfoxide (DMSO, Thermo Fisher Scientific, Massachusetts, USA)] for 15 days, renewing the medium for the first three days and then every three days. Once differentiated, HepaRG cells were washed twice with PBS and serodeprived for 2 h. The cells were then cultured with high glucose (4.5 g/L) and high insulin (100 nM), with palmitate [500 µM in 2% fatty acid-free BSA (Capricorn Scientific, USA)], oleic acid [1 mM, conjugated in 0.5 mM fatty acid-free BSA (Capricorn Scientific, USA)], or with combination treatment [glucose (4.5 g/L) and insulin (100 nM), 250 µM palmitate (Sigma-Aldrich, MO, USA) in 2% fatty acid-free BSA (Capricorn Scientific, USA) and 0.5 mM oleic acid (Sigma-Aldrich, MO, USA), conjugated in 0.5 mM fatty acid-free BSA (Capricorn Scientific)]. For RNA or protein extraction, the treatment was performed for 24 h, whereas for the isolation of vesicles from the cell secretome, the treatment was prolonged to 48 h.
Murine hepatocyte primary cell culture was obtained by hepatic perfusion of 14-week-old male C57BL/6 mice weighing 20 g following previously described protocols [21 (link), 22 (link)]. Hepatocytes from the perfusion were resuspended in 100 mL of complete medium [DMEM (Gibco) with 10% FBS (Lonza) and 1% P/S (Gibco)], divided into 2 × 50 mL tubes, and centrifuged at 400 rpm (SorvallTM ST16, Fisher Scientific) for 4 min. The pellet was resuspended in 30 mL complete medium and 15 mL 90% Percoll (GE Healthcare) and centrifuged at 500 rpm for 10 min. Subsequently, the cell pellet from both tubes was transferred to a single tube, resuspended in complete medium, and centrifuged three times at 500 rpm for 5 min 3 times. Finally, the pellet of hepatocytes was resuspended in 50 mL of complete medium to analyze cell viability by Trypan Blue staining on slides (Cell Counting Chamber Slides, Invitrogen) for cell counting using the Countess® equipment (Invitrogen). Once the viability of the hepatocytes was obtained, 250.000 cells were seeded in 9.2 cm2 plates (Corning, Thermo Fisher Scientific, Massachusetts, USA) previously treated with collagen (Sigma-Aldrich, MO, USA).
+ Open protocol
+ Expand
10

Mesenchymal Stem Cell Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs were cultured in T25 flasks for 21 days to induce osteogenic and adipogenic differentiation. Once cells reached 100% confluence, they were washed with PBS, and MesenCult® Adipogenic and Osteogenic Stimulatory Supplements (STEMCELL Technologies, Canada) were added. After 3 weeks, cells were fixed in formalin and stained with Oil Red O (Sigma, USA) and Alizarin Red (Sigma-Aldrich) to assess adipogenic and osteogenic differentiation, respectively. Images were captured using an Olympus IX73 microscope with Olympus cellSens imaging software at 10 × magnification (NA:0.25/W.D:10 mm). The presence of adipocytes was determined using Oil Red O staining, an indicator of intracellular lipid accumulation. Lipid droplets were counted in five different fields, and the percentage of Oil Red O-positive MSCs was calculated by averaging the percentages. The analysis of osteogenic differentiation was performed by counting the bone nodules observed in five different fields under a light microscope (Olympus IX73). The counting was conducted independently by two different researchers to ensure accuracy and eliminate observer bias (Azadniv et al. 2020 (link)).
MSC surface markers were also analyzed using flow cytometry. Cells were stained with CD45-Alexa Flour® 488 (BioLegend, cat. no. 304019), CD34-FITC (BioLegend, cat. no. 343604) antibody staining and positive CD90-PE (BioLegend, cat. no. 328110), CD73-APC (BioLegend, cat. no.344006), and CD105-PE/Cy7 (BioLegend, cat. no. 323218) and analyzed on Navios-Beckman Coulter flow cytometer using Navios Software v1.2.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!

🧪 Need help with an experiment or choosing lab equipment?
I search the PubCompare platform for you—tapping into 40+ million protocols to bring you relevant answers from scientific literature and vendor data.
1. Find protocols
2. Find best products for an experiment
3. Validate product use from papers
4. Check Product Compatibility
5. Ask a technical question
Want to copy this response? Upgrade to Premium to unlock copy/paste and export options.